Physician profile
Brian Bower
NPI 1558341453
$2,848.50
in general payments reported to CMS, 2019-2025
20 companies · $401 in 2025
The $401 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $581 · 2020: $314 · 2021: $551 · 2022: $546 · 2023: $256 · 2024: $199 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758 · Education: $98.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.04 |
| Education | $98.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $464.12 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $331.49 | 2021-2022 | |
| Smith+Nephew, INC. | $325.27 | 2022-2023 | Pico 7, Pico 14 |
| Bayer Healthcare Pharmaceuticals INC. | $237.20 | 2019-2025 | |
| Organon LLC | $199.79 | 2021-2025 | Nexplanon |
| Sage Therapeutics, LLC | $194.18 | 2024-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $172.18 | 2019-2021 | |
| Minerva Surgical, INC | $159.64 | 2025 | |
| Pfizer INC. | $136.72 | 2019-2024 | |
| Intuitive Surgical, INC. | $109.22 | 2023 | Da Vinci Surgical System |
| Coopersurgical, INC. | $95.00 | 2019 | |
| Agile Therapeutics, INC. | $92.49 | 2021-2022 | |
| Medical Device Business Services, INC. | $86.66 | 2019 | |
| Astellas Pharma US INC | $66.56 | 2024-2025 | Veozah |
| Ethicon US, LLC | $65.42 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $42.32 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.60 | 2019 | |
| Myovant Sciences INC. | $22.93 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.91 | 2019 | |
| Avion Pharmaceuticals | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.